Related Experiment Video

Updated: Aug 13, 2026

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting
11:58

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting

Published on: March 8, 2018

Pharmacokinetics of anti-endocrine agents

P E Lønning1, E A Lien

  • 1Department of Oncology, Univeristy of Bergen, Haukeland Hospital.

Cancer Surveys
|January 1, 1993
PubMed

Insights

Understanding tamoxifen and progestin drug disposition is crucial for cancer treatment. Further research is needed to clarify drug absorption, tissue distribution, and potential interactions for improved endocrine therapy outcomes.

Area of Science:

  • Oncology
  • Pharmacology
  • Endocrinology

Background:

  • Endocrine therapy is vital for treating breast, prostate, and gynecological cancers.
  • Tamoxifen, an anti-estrogen, has treated over two million women, yet its disposition remains unclear.
  • Uncertainty exists regarding the absorption fractions and plasma pharmacokinetics of tamoxifen and progestin drugs.

Purpose of the Study:

  • To investigate the incomplete understanding of tamoxifen and progestin drug disposition.
  • To address the lack of certainty in absorption fractions and plasma pharmacokinetic data.
  • To highlight the need for further studies on tissue distribution, drug interactions, and long-term effects.

Main Methods:

  • Review of existing pharmacokinetic studies on tamoxifen and progestin drugs.
  • Analysis of limitations in blood sampling times for determining terminal half-life.
  • Identification of data gaps concerning tissue and tumor drug concentrations.

Main Results:

  • Many studies lack sufficient data on drug absorption and terminal half-life determination.
  • Information on tissue and particularly tumor drug concentrations is generally lacking.
  • Potential confounding factors like drug interactions (e.g., aminoglutethimide) are noted.

Conclusions:

  • Further research should compare tissue and tumor distribution with treatment response.
  • Evaluation of drug interactions is essential for combined endocrine therapies.
  • Long-term effects, including teratogenicity, require investigation, especially with increasing tamoxifen use in premenopausal women.

More Related Videos

Detection of Antibodies That Neutralize the Cellular Uptake of Enzyme Replacement Therapies with a Cell-based Assay07:52

Detection of Antibodies That Neutralize the Cellular Uptake of Enzyme Replacement Therapies with a Cell-based Assay

Published on: September 10, 2018

Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction11:02

Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction

Published on: September 14, 2018

Related Concept Videos

Drug Distribution: Tissue Binding01:21

Drug Distribution: Tissue Binding

Upon entering the systemic circulation, drugs can distribute into the interstitial and intracellular fluid of various tissue cells. This distribution is facilitated by the binding of drugs to different cellular components within tissues, which may lead to drug accumulation in specific areas. Drugs bound to tissue components serve as reservoirs that release free drugs back into the system, prolonging the drug's overall action. However, this accumulation can also result in local toxicity.
For...
Drug Distribution: Plasma Protein Binding01:29

Drug Distribution: Plasma Protein Binding

Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...
Antibody Actions01:26

Antibody Actions

Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Drug Binding to Blood Components01:30

Drug Binding to Blood Components

When drugs enter systemic circulation, they interact with various components of the blood, including proteins such as human serum albumin (HSA), α1-acid glycoprotein (AAG), lipoproteins, globulins, and red blood cells (RBCs).
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are further...
Measurement of Bioavailability: Pharmacokinetic Methods01:30

Measurement of Bioavailability: Pharmacokinetic Methods

Pharmacokinetics is a vital branch of pharmacology that examines how drugs are absorbed, distributed, metabolized, and excreted by the body. Two key methodologies in pharmacokinetics are plasma drug concentration studies and urinary drug excretion analyses, both of which provide critical insights into a drug's therapeutic efficacy and bioavailability.Plasma Drug Concentration-Time StudiesPlasma drug concentration-time studies involve analyzing blood samples at specific intervals to quantify...
Measurement of Bioavailability: Pharmacodynamic Methods01:20

Measurement of Bioavailability: Pharmacodynamic Methods

Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.